A patient with a severe scleroedema diabeticorum, partially responding to low-dose methotrexate [5]

Dermatology

Volumn 198, Issue 2, 1999, Pages 177-179

  Seyger, Marieke M B ^a   Van Den Hoogen, F H J ^b   De Mare, S ^b   Van Haelst, U ^b   De Jong, E M G J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; CASE REPORT; DIABETES MELLITUS; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; SCLEROEDEMA DIABETICORUM; SKIN DISEASE; SKINFOLD;

ADULT; DERMATOLOGIC AGENTS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; METHOTREXATE; SCLEREDEMA ADULTORUM;

EID: 0032912479     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018103     Document Type: Letter

References (16)

1. Gilgor RS, Lazarus GS: Skin manifestations of diabetes mellitus; in Rifkin H, Raskin P (eds): Diabetes mellitus. Bowie, Brady Co, 1981, pp 313-321.
2. Curtis AC, Shulak BM: Scleredema adultorum: Not always a benign self-limited disease. Arch Dermatol 1965;92:526-541.
3. Sattar MA, Diab S, Sugathan TN, Sivanandasingham P, Fenech FF: Scleroedema diabeticorum: A minor but often unrecognized complication of diabetes mellitus. Diabet Med 1988;5:465-468.
4. Huntley AC: The cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1982;7:427-455.
5. Rho YW, Suhr KB, Lee JH, Park JK: A clinical observation of scleredema adultorum and its relationship to diabetes. J Dermatol 1998;25:103-107.
6. van den Hoogen FH, Boerbooms AM, Swaak AJ, Rasker JJ, van Lier HJ, van de Putte LB: Comparison of methotrexate with placebo in the treatment of systemic sclerosis: A 24-week randomized double-blind trial, followed by a 24-week observational trial. Br J Rheumatol 1996;35:364-372.
7. Kunzelmann V, Schnelle C, Audring H, Brenke A, Harnack K: Scleroedeme diabeticorum: Ein Bericht über vier Fälle. Hautarzt 1996;47:214-217.
8. Jelinek JE: Cutaneous manifestations of diabetes mellitus. In J Dermatol 1994;33:605-617.
9. Venencie PY, Powell FC, Su WP, Perry HO: Scleredema: A review of thirty-three cases. J Am Acad Dermatol 1984;11:128-134.
10. Fleischmajer R, Perlish JS: Glycosaminoglycans in scleroderma and scleredema. J Invest Dermatol 1972;58:129-132.
11. Kobayashi T, Yamasaki Y, Watanabe T: Diabetic scleredema: A case report and biochemical analysis for glycosaminoglycans. J Dermatol 1997;24: 100-103.
12. Cole GW, Headley J, Skowsky R: Scleredema diabeticorum: A common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care 1983;6:189-192.
13. Fleischmajer R, Faludi G, Krol S: Scleredema and diabetes mellitus. Arch Dermatol 1970;101:21-26.
14. Hager CM, Sobhi HA, Hunzelmann N, Wickenhauser C, Scharenberg R, Krieg T, Scharffetter Kochanek K: Bath-PUVA therapy in three patients with scleredema adultorum. J Am Acad Dermatol 1998;38:240-242.
15. Vishwanath V, Frank KE, Elmets CA, Dauchot PJ, Monnier VM: Glycation of skin collagen in type I diabetes mellitus: Correlation with long-term complications. Diabetes 1986;35:916-921.
16. Sternberg M, Urios P, Grigorova Borsos AM: Effets du processus de glycation sur la structure macromoléculaire des membranes basales glomérulaires et sur les fonctions glomérulaires au cours du vieillissement et du diabète sucré. C R Séances Soc Biol Fil 1995;189:967-985.